Menu Close

Trending

Merck makes circular RNA play with $3.5bn Orna alliance
On heels of new data, Gilead pays $455m for Asian Trodelvy rights
Roche eyes April FDA verdict on Polivy as first-line lymphoma therapy
Digital health’s rapid growth spurt comes home to roost
FDA grants swift review to Lynparza in first-line prostate cancer

unmet need

Molecular, DNA and atom model in science research lab

Market Access/ Patients/ Views & Analysis/ Views & Analysis/ Views and analysis

Rare Disease Day: How the patient voice can tear down barriers

, , , , , , , 0 Comment

To have any impact, patient engagement needs to start with the drug development pathway, not at the point

X
Rare Disease Day: How the patient voice can tear down barriers
https://pharmaphorum.com/views-and-analysis/rare-disease-day-how-the-patient-voice-can-tear-down-barriers/
the-patient-voice-imageC

Patients/ Views & Analysis/ Views and analysis

Increasing patient involvement in research to tackle unmet need

, , , , , 0 Comment

It could be said that there is no greater unmet need than a complete and absolute absence of treatment

X
Increasing patient involvement in research to tackle unmet need
https://pharmaphorum.com/views-and-analysis/increasing-patient-involvement-research-tackle-unmet-need/

Login

CONTINUE TO SITE >
X
Close in 10 seconds